Lauren Bogdan, MD
Otolaryngology · Wilmington, DENPI 1659767028
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $637, 5.6 times the $115 reported in 2021. That places this record below the midpoint for otolaryngology clinicians in DE, where the typical reported total is $1,648.
Across 78 payments — averaging $21.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$333
- CSL Behring$303
- Takeda Pharmaceuticals U.S.A., Inc.$156
- Biocryst US Sales Co., LLC$121
- Genentech USA, Inc.$106
- Sanofi$91
- plus $538 from 17 others
What the payments were for
- Food & beverage$1,648100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 19 | $333 |
| CSL Behring | 12 | $303 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $156 |
| Biocryst US Sales Co., LLC | 4 | $121 |
| Genentech USA, Inc. | 4 | $106 |
| Sanofi | 3 | $91 |
| Alk-abello, Inc | 3 | $70 |
| Inspire Medical Systems, Inc. | 2 | $62 |
| Acclarent, Inc | 3 | $53 |
| GSK | 3 | $50 |
| Stryker | 2 | $38 |
| Kedrion Biopharma, Inc. | 2 | $35 |
| Biohaven Pharmaceuticals, Inc. | 2 | $35 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $33 |
| AstraZeneca | 2 | $30 |
| Kaleo, Inc. | 1 | $22 |
| Ionis Pharmaceuticals, Inc. | 1 | $18 |
| Greer Laboratories, Inc. | 1 | $17 |
| Grifols USA, LLC | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Davol Inc. | 1 | $15 |
| Hikma Pharmaceuticals USA | 1 | $15 |
| Aerin Medical Inc. | 1 | $13 |
How this compares
$1,648 in reported general payments places this provider in the 50th percentile of 27 otolaryngology providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 38 | $1,440 |
| Ipratropium Bromide | 34 | $1,101 |
| Fluticasone Propionate | 94 | $951 |
| Omeprazole | 26 | $311 |
| Nortriptyline Hcl | 11 | $240 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 12 | $187 |
| Mupirocin | 14 | $86 |
| Methylprednisolone | 12 | $75 |
| Prednisone | 14 | $37 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Wilmington
- Paul ImberWilmington$5K
- Udayan ShahWilmington$5K
- Joan CokerWilmington$3K
- Michael TeixidoWilmington$3K
- Mindy RabinowitzWilmington$3K
- Neil HocksteinWilmington$2K
- Kieran ConnollyWilmington$2K
- Emilio ValdesWilmington$413
- Timoteo GabrielWilmington$157
- James ReillyWilmington$95
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.